INFU
InfuSystems Holdings Inc
NYSE MKT: INFU · HEALTHCARE · MEDICAL DEVICES
$10.13
+3.05% today
Updated 2026-04-30
Market cap
$215.27M
P/E ratio
34.39
P/S ratio
1.50x
EPS (TTM)
$0.31
Dividend yield
—
52W range
$5 – $11
Volume
0.1M
InfuSystems Holdings Inc (INFU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
4.62%
Operating margin
4.73%
ROE
11.50%
ROA
6.69%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-7.86M | — | — | — |
| 2007 | $6.58M | $-2.80M | 75.39% | -22.74% | -42.48% |
| 2008 | $35.41M | $9.96M | 74.05% | 13.51% | 28.12% |
| 2009 | $38.96M | $774000.00 | 73.50% | 13.67% | 1.99% |
| 2010 | $47.23M | $-1.85M | 71.03% | -1.99% | -3.92% |
| 2011 | $54.64M | $-45.44M | 64.71% | -121.45% | -83.17% |
| 2012 | $58.83M | $-1.49M | 72.94% | 3.40% | -2.53% |
| 2013 | $62.28M | $1.67M | 70.13% | 9.47% | 2.68% |
| 2014 | $66.49M | $3.36M | 71.22% | 14.03% | 5.05% |
| 2015 | $72.13M | $3.74M | 70.97% | 12.29% | 5.19% |
| 2016 | $70.50M | $-222000.00 | 63.46% | 1.38% | -0.31% |
| 2017 | $71.08M | $-20.71M | 61.01% | -5.36% | -29.13% |
| 2018 | $67.14M | $-1.09M | 58.12% | 0.62% | -1.63% |
| 2019 | $81.11M | $1.36M | 57.80% | 4.35% | 1.68% |
| 2020 | $97.39M | $17.33M | 60.33% | 9.06% | 17.80% |
| 2021 | $102.38M | $1.42M | 57.17% | 2.75% | 1.39% |
| 2022 | $109.91M | $18000.00 | 55.10% | 1.50% | 0.02% |
| 2023 | $125.78M | $872000.00 | 50.17% | 3.25% | 0.69% |
| 2024 | $134.86M | $2.35M | 52.20% | 5.11% | 1.74% |
| 2025 | $143.44M | $6.63M | 55.98% | 8.31% | 4.62% |